The management of risk factors and timely revascularisation continues to reduce the morbidity and mortality from cardiovascular disease. Despite good evidence for reduced mortality on statins and decades of promotion, population uptake globally is less than 3%, and only around 10% even in the United Kingdom and the United States. Statins remain the only cholesterol-lowering...